FindTrial
Sign In

Study on the effect of Hepatitis B virus on haemopoietic stem cell

Study on the effect of Hepatitis B virus on haemopoietic stem cell

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCC-11001394
Enrollment
Unknown
Registered
2011-06-09
Start date
2010-07-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic hepatitis B

Interventions

group1:cord blood come from healthy control delivery woma
group2:cord blood come from HBsAg+,HBeAg+delivery woman
group3:Chronic hepatitis B volunteers bone marrow

Sponsors

The first clinical hosptial of Harb Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1 HBsAg+, HBeAg+delivery women; 2 healthy delivery women;chronic hepatitis B patients; 3. healthy volunteers

Exclusion criteria

Exclusion criteria: 1. HBsAg+, HBeAg+delivery women who have chronic or acute hepatitis C; 2. Healthy delivery women who have other acute hepatitis and the blood system diseases; 3. Chronic hepatitis B volunteers who have chronic hepatitis C.

Design outcomes

Primary

MeasureTime frame
Stem cell come from cord blood of HBsAg+, HBeAg+delivery women whether or not infected by HBV;Stem cell come from cord blood of healthy contol group whether or not infected HBV in vitro;Immune function of stem cell come from Chronic hepatitis B volunteers bone marrow;—

Countries

China

Contacts

Public ContactYongguo Li
liyongguo@54dr.com+86 0451 85555197

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026